# FDA Inspection 1326794 - InvaGen Pharmaceuticals, Inc. - July 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/14318d7e-137b-4a63-be03-7007c9e3c909
Source feed: FDA_Inspections

> FDA Inspection 1326794 for InvaGen Pharmaceuticals, Inc. on July 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326794
- Company Name: InvaGen Pharmaceuticals, Inc.
- Inspection Date: 2026-07-17
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1218990 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/bcdad572-3ffb-4796-b39c-4a3ad562402b)
- [FDA Inspection 1218990 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/9fbc57a6-7e6f-45f8-814a-87acbc9c0b7d)
- [FDA Inspection 1075033 - 2018-12-19](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/472553cc-1bf5-4a04-b2f5-3f9bc69a830d)
- [FDA Inspection 1019854 - 2017-05-26](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/0ae8efd8-6667-41d2-b2f2-b3fc68dacae6)

Company: https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/4edf588a-64bd-4eba-9755-cbf216710d03

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d